MIB-1 (Ki-67), estrogen receptor, progesterone receptor, and p53 expression in atypical cells in uterine symplastic leiomyomas

International Journal of Gynecological Pathology

Volumn 29, Issue 1, 2010, Pages 51-54

  Sun, Xichun ^a   Mittal, Khush ^a  

^a BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

Atypical leiomyoma; Estrogen receptors; Ki 67; P53; Progesterone receptors; Symplastic leiomyoma

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER RECURRENCE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; MITOSIS RATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYMPLASTIC UTERINE LEIOMYOMA; UTERUS MYOMA;

ADULT; AGED; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LEIOMYOMA; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UTERINE NEOPLASMS;

EID: 76149129383     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181b0259b     Document Type: Article

References (14)

1. Zaloudek CJ, Norris HJ. Mesenchymal tumors of the uterus. In: Kurman RJ, ed. Blausteins's Pathology of the Female Genital Tract. 5th ed. New York: Springer-Verlag; 2002:561-615.
2. Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms: a clinicopathologic study of 213 cases. Am J Surg Pathol 1994;18:535-558
3. Burns B, Curry RH, Bell MEA. Morphologic features of prognostic significance in uterine smooth muscle tumors: a review of eighty-four cases. Am J Obstet Gynecol 1979; 135:109-114
4. Evans HL, Chawla SP, Simpson C, et al. Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer 1988;62:2239-2247
5. Downes KA, Hart WR. Bizarre leiomyomas of the uterus: a comprehensive pathologic study of 24 cases with long term follow-up. Am J Surg Pathol 1997;21:1261-1270
6. Kelly HA, Cullen TS. Myomata of the Uterus. Philadelphia: WB Saunders; 1909.
7. Przybora LA. Leiomyosarcoma in situ of the uterus. Cancer 1961;14:483-492
8. Mittal K, Joutovsky A. Areas with benign morphologic and immunohistochemical features are associated with some uterine leiomyosarcomas. Gynecol Oncol 2007;104:362-365
9. Ernst LM, Luo FF, Parkash V, et al. Increased global DNA methylation in symplastic leiomyomas. Mod Pathol 2002; 25:196A.
10. Liu LM, Zhang JG, Bates S, et al. A methylation profile of in vitro immortalized human cell lines. Int J Oncol 2005; 26:275-285
11. Gokaslan H, Turkeri L, Kavak ZN, et al. Differential diagnosis of smooth muscle tumors utilizing p53, pTEn and Ki-67 expression with estrogen and progesterone receptors. Gynecol Obstet Invest 2005;59:36-40.
12. Amada S, Nakano H, Tsuneyoshi M. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the Mib-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins. Int J Gynecol Pathol 1995;14:134-142
13. Zhai YL, Kobayashi Y, Mori A, et al. Expression of Steriod receptors, Ki-67, p53, in uterine leiomyosarcomas. Int J Gynecol Pathol 1999;18:20-28
14. Chen L, Yang B. Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors. Int J Gynecol Pathol 2008;27:326-332